Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2017 1
2020 3
2021 1
2023 1
2024 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacological treatments of COVID-19.
Sahebnasagh A, Avan R, Saghafi F, Mojtahedzadeh M, Sadremomtaz A, Arasteh O, Tanzifi A, Faramarzi F, Negarandeh R, Safdari M, Khataminia M, Rezai Ghaleno H, Habtemariam S, Khoshi A. Sahebnasagh A, et al. Among authors: khataminia m. Pharmacol Rep. 2020 Dec;72(6):1446-1478. doi: 10.1007/s43440-020-00152-9. Epub 2020 Aug 20. Pharmacol Rep. 2020. PMID: 32816200 Free PMC article. Review.
The Potential of Cannabidiol for Acute Respiratory Distress Syndrome in COVID-19.
Azimi S, Saghafi F, Mohammadi MH, Moghimi MH, Akhavan SA, Khataminia M, Shirvani M, Sohrevardi SM, Jamialahmadi T, Sahebnasagh A, Sahebkar A. Azimi S, et al. Among authors: khataminia m. Curr Pharm Des. 2023;29(29):2291-2296. doi: 10.2174/0113816128275803230920094909. Curr Pharm Des. 2023. PMID: 37818584 Review.
The prophylaxis and treatment potential of supplements for COVID-19.
Sahebnasagh A, Saghafi F, Avan R, Khoshi A, Khataminia M, Safdari M, Habtemariam S, Ghaleno HR, Nabavi SM. Sahebnasagh A, et al. Among authors: khataminia m. Eur J Pharmacol. 2020 Nov 15;887:173530. doi: 10.1016/j.ejphar.2020.173530. Epub 2020 Sep 1. Eur J Pharmacol. 2020. PMID: 32882216 Free PMC article. Review.
Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19.
Sahebnasagh A, Saghafi F, Safdari M, Khataminia M, Sadremomtaz A, Talaei Z, Rezai Ghaleno H, Bagheri M, Habtemariam S, Avan R. Sahebnasagh A, et al. Among authors: khataminia m. J Clin Pharm Ther. 2020 Dec;45(6):1515-1519. doi: 10.1111/jcpt.13251. Epub 2020 Aug 28. J Clin Pharm Ther. 2020. PMID: 32860252 Review.